April 20th every year is World Gout Day. Ye Zhiming, Director of the Nephrology Department at Guangdong Provincial People's Hospital, stated that chronic inflammation caused by long-term high uric acid levels can accelerate kidney damage and damage kidney tissue. For patients, improving screening awareness, rational drug use, and strict uric acid management are the three lines of defense to protect the kidneys.
In recent years, with the rapid growth of hyperuricemia population, gouty nephropathy is threatening people's kidney health.
Ye Zhiming pointed out that gouty nephropathy is divided into two types: acute and chronic. Acute gouty nephropathy is commonly seen after chemotherapy for tumors or hematological diseases, where massive cell necrosis leads to a sudden increase in uric acid and blockage of renal tubules, resulting in sudden oliguria, anuria, and even acute uremia. Chronic gouty nephropathy is more common, caused by long-term hyperuricemia leading to chronic inflammation and oxidative stress in the kidneys, resulting in vascular and interstitial fibrosis, as well as uric acid stones blocking the urinary tract, ultimately leading to chronic renal insufficiency.
"At present, the onset age of gout is significantly earlier, and patients in their 20s are not rare." Ye Zhiming stressed that gouty nephropathy has an obvious trend of youth, and people over 40 years old and those with genetic background and high purine diet habits are particularly at risk, and the risk of combined metabolic diseases such as diabetes and hypertension is doubled.
Traditional treatment relies on low purine diet, uric acid excretion promoting drugs, and alkalinization of urine, but some patients may worsen kidney damage due to long-term use of nonsteroidal anti-inflammatory drugs.
Ye Zhiming mentioned that there are currently innovative interleukin-1 β targeted biologics that bring a turning point to treatment. This therapy does not go through liver and kidney metabolism, but directly inhibits the core factor IL-1 β of gout inflammation, which is safer for patients with impaired kidney function and avoids drug-induced kidney damage during treatment.
Early detection is the core of prevention and treatment. Ye Zhiming suggests that the general population should regularly screen for signs of kidney disease through non-invasive tests such as urine routine and renal ultrasound, while gout or hyperuricemia patients need to strictly monitor their blood uric acid levels. If uric acid can be controlled before the onset of kidney disease, patients may not progress to the stage of kidney disease for life; those who are already ill need to control uric acid below 5.5mg/dL
Regarding the daily management of patients, Ye Zhiming reminds that timely hydration after exercise is crucial to prevent urine concentration from accelerating uric acid deposition. In addition, he called on the public to reduce their intake of high sugar beverages, alcohol, and high purine diets.

